Imagion Biosystems announces that Ms Jovanka Naumoska has resigned from her position as Company Secretary of Imagion Biosystems, effective today, 8 December 2020. Ms Naumoska wil remain on the Board as a Non-Executive Director.
The Company has appointed Mr. Geoff Hollis as Company Secretary, effective today. Mr. Hollis was recently appointed as the Company’s Chief Financial Officer.
Read the full announcement at ASX.
MELBOURNE – Imagion Biosystems (Company) (ASX : IBX), a company dedicated to improving healthcare outcomes through the early detection of cancer, is pleased to announce
Corporate Updates: $3M fundraising led by CPS Capital to be completed in early December Filing of IND for MagSense® HER2 Phase 2 Study Immediate Priority
Imagion Biosystems (ASX: IBX) (Company), is pleased to announce the Company has received $3 million of firm commitments through a highly successful capital raising. The
We’re on a mission to make cancer more detectable.
Imagion Biosystems (IBX) is an innovative medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases.
Stay informed about our latest news and developments.
© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance